COVID-19

R&D

New ways to treat COVID: the pharmaphorum podcast

In episode 31 of the pharmaphorum podcast, Deep Dive editor George Underwood speaks to RedHill biopharma’s chief business officer Guy Goldb

News

Sanofi/Translate start clinical trial of mRNA COVID shot

Sanofi and Translate BIO have begun a clinical trial of their potential mRNA COVID-19 shot, as the French pharma struggles to keep pace with rivals despite its background in vaccines.

News

J&J’s COVID-19 shot backed for emergency use in EU

The EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot from Johnson & Johnson’s Janssen unit – after a review by it

Views & Analysis

Meeting public expectations of diagnostics is the next big t...

Ivor Campbell looks at the way the UK medtech sector has responded to COVID-19 and the implications of more advanced diagnostics for prescribing and general practice.

News

Clear COVID health information essential for a return to healthcare as normal

Pharma poised to cash in on 'long COVID' symptoms

While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue to affect patients for some time.

News

Pfizer/BioNTech COVID jab works against Brazil variant; lab ...

A laboratory study suggests Pfizer and BioNTech’s COVID-19 vaccine Comirnaty could be effective against a Brazilian variant of the SARS-CoV-2 virus – known as P.1 – that is worrying health

New ways to treat COVID: the pharmaphorum podcast

Sanofi/Translate start clinical trial of mRNA COVID shot

J&J’s COVID-19 shot backed for emergency use in EU

Meeting public expectations of diagnostics is the next big t...

Pharma poised to cash in on 'long COVID' symptoms

Pfizer/BioNTech COVID jab works against Brazil variant; lab ...

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks